These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 33114519)

  • 1. Short Term Presence of Subretinal Fluid in Central Serous Chorioretinopathy Affects Retinal Thickness and Function.
    Gawęcki M; Jaszczuk A; Grzybowski A
    J Clin Med; 2020 Oct; 9(11):. PubMed ID: 33114519
    [No Abstract]   [Full Text] [Related]  

  • 2. Ganglion Cell Loss in the Course of Central Serous Chorioretinopathy.
    Gawęcki M; Grzybowski A
    Ophthalmol Ther; 2023 Feb; 12(1):517-533. PubMed ID: 36510030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy.
    Gawęcki M; Jaszczuk-Maciejewska A; Jurska-Jaśko A; Kneba M; Grzybowski A
    BMC Ophthalmol; 2019 Jul; 19(1):160. PubMed ID: 31345183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central Serous Chorioretinopathy: Morphological and Functional Outcome after Subthreshold Thermal Laser Coagulation with a Frequency-Doubled Nd:YAG Continuous-Wave Laser.
    Enders C; Lang GE; Mayer B; Werner JU
    Ophthalmologica; 2022; 245(1):59-68. PubMed ID: 34517369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visual and anatomical evaluation of navigated subthreshold micropulse laser versus photodynamic therapy in managing chronic central serous chorioretinopathy.
    Toto L; Ares I; Quarta A; Viggiano P; Ruggeri M; Formenti F; Boscia G; Porreca A; Di Nicola M; Boscia F; Mastropasqua R
    Graefes Arch Clin Exp Ophthalmol; 2024 Oct; ():. PubMed ID: 39425791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Half-dose photodynamic therapy followed by diode micropulse laser therapy as treatment for chronic central serous chorioretinopathy: evaluation of a prospective treatment protocol.
    Breukink MB; Mohr JK; Ossewaarde-van Norel A; den Hollander AI; Keunen JE; Hoyng CB; Boon CJ
    Acta Ophthalmol; 2016 Mar; 94(2):187-97. PubMed ID: 26670630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crossover to PDT after the unsuccessful micropulse laser treatment of central serous chorioretinopathy.
    Gawęcki M; Kiciński K; Grzybowski A
    Adv Ophthalmol Pract Res; 2024; 4(1):32-38. PubMed ID: 38406665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfoveal Micropulse Laser Treatment of Central Serous Chorioretinopathy within Six Months of Disease Onset.
    Gawęcki M; Jaszczuk-Maciejewska A; Jurska-Jaśko A; Kneba M; Grzybowski A
    J Clin Med; 2019 Sep; 8(9):. PubMed ID: 31500100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significant Visual Impairment after Short-Lasting Central Serous Chorioretinopathy.
    Gawęcki M; Grzybowski A; Pompein-Batkiewicz M
    Case Rep Ophthalmol; 2022; 13(3):678-685. PubMed ID: 36742018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subthreshold diode micropulse photocoagulation for the treatment of chronic central serous chorioretinopathy with juxtafoveal leakage.
    Chen SN; Hwang JF; Tseng LF; Lin CJ
    Ophthalmology; 2008 Dec; 115(12):2229-34. PubMed ID: 19041477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective retina therapy (SRT) in patients with therapy refractory persistent acute central serous chorioretinopathy (CSC): 3 months functional and morphological results.
    Büttner M; Luger B; Abou Moulig W; Junker B; Framme C; Jacobsen C; Knoll K; Pielen A;
    Graefes Arch Clin Exp Ophthalmol; 2021 Jun; 259(6):1401-1410. PubMed ID: 33205239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photodynamic therapy in chronic central serous chorioretinopathy with subretinal fluid outside the fovea.
    van Dijk EHC; Dijkman G; Boon CJF
    Graefes Arch Clin Exp Ophthalmol; 2017 Oct; 255(10):2029-2035. PubMed ID: 28674835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Subthreshold Micropulse Laser for Central Serous Chorioretinopathy.
    Fasler K; Turgut F; Gunzinger JM; Sommer C; Muth DR; Kinzl S; Nilius H; Zweifel S; Somfai GM
    Klin Monbl Augenheilkd; 2024 Apr; 241(4):489-495. PubMed ID: 38653299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One year outcome and predictors of treatment outcome in central serous chorioretinopathy: Multimodal imaging based analysis.
    Arora S; Maltsev DS; Singh Randhir S; Sahoo NK; Jhingan M; Parmeshwarappa D; Arora T; Kulikov A; Iovino C; Zur D; Fainberg G; Ibrahim MN; Tatti F; Gujar R; Venkatesh R; Reddy N; Snehith R; Peiretti E; Lupidi M; Chhablani J
    Eur J Ophthalmol; 2022 Jul; 32(4):2319-2327. PubMed ID: 34747194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baseline Predictive Factors of Visual Outcome and Persistence of Subretinal Fluid Based on Morphologic Changes in Spectral Domain Optical Coherence Tomography in Patients with Idiopathic Central Serous Chorioretinopathy.
    Suwal B; Khadka D; Shrestha A; Shrestha S; Shrestha N; Khatri B
    Clin Ophthalmol; 2019; 13():2439-2444. PubMed ID: 31849441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional and morphological outcome in patients with chronic central serous chorioretinopathy treated by subthreshold micropulse laser.
    Gawęcki M; Jaszczuk-Maciejewska A; Jurska-Jaśko A; Grzybowski A
    Graefes Arch Clin Exp Ophthalmol; 2017 Dec; 255(12):2299-2306. PubMed ID: 28831603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anatomical and Functional Changes of the Retina and the Choroid after Resolved Chronic CSCR.
    Toto L; D'Aloisio R; Mastropasqua R; Di Antonio L; Di Nicola M; Di Martino G; Evangelista F; Erroi E; Doronzo E; Mariotti C
    J Clin Med; 2019 Apr; 8(4):. PubMed ID: 30959979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Routine Clinical Practice Treatment Outcomes of Eplerenone in Acute and Chronic Central Serous Chorioretinopathy.
    Fasler K; Gunzinger JM; Barthelmes D; Zweifel SA
    Front Pharmacol; 2021; 12():675295. PubMed ID: 34040534
    [No Abstract]   [Full Text] [Related]  

  • 19. Three-Year Results of Fluorescein Angiography-Guided Standard Photodynamic Therapy with Multiple Spots for Central Serous Chorioretinopathy.
    Ladas ID; Andreanos KD; Ladas DS; Moschos MM; Rotsos T; Kotsolis AI
    Ophthalmol Retina; 2018 Jul; 2(7):703-711. PubMed ID: 31047379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regression patterns of central serous chorioretinopathy using en face optical coherence tomography.
    Arora S; Rosario B; Mohammed AR; Beale O; Selvam A; Venkatesh R; Maltsev DS; Chhablani J;
    Graefes Arch Clin Exp Ophthalmol; 2022 Aug; 260(8):2475-2481. PubMed ID: 35357548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.